Breast Findings in Females With Beckwith-Wiedemann Syndrome.
1/5 보강
Beckwith-Wiedemann syndrome (BWS) is an overgrowth condition caused by epigenetic defects on chromosome 11p15.
APA
Grossmann LD, George AM, et al. (2026). Breast Findings in Females With Beckwith-Wiedemann Syndrome.. Pediatric blood & cancer, 73(1), e32109. https://doi.org/10.1002/pbc.32109
MLA
Grossmann LD, et al.. "Breast Findings in Females With Beckwith-Wiedemann Syndrome.." Pediatric blood & cancer, vol. 73, no. 1, 2026, pp. e32109.
PMID
41074634 ↗
Abstract 한글 요약
Beckwith-Wiedemann syndrome (BWS) is an overgrowth condition caused by epigenetic defects on chromosome 11p15. Children with BWS have a predisposition to embryonal tumors such as Wilms tumor and hepatoblastoma. However, few reports of breast tumors in females with BWS have been published and the risk of malignancy and need for screening remains unknown. In this report, we describe six adolescent or adult females with BWS who developed benign or malignant breast tumors. Additionally, we conducted a review of the literature to compare our findings with previously reported cases.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- Early local immune activation following intra-operative radiotherapy in human breast tissue.
- SpNeigh: spatial neighborhood and differential expression analysis for high-resolution spatial transcriptomics.
- Impact of Comorbidities on Clinical Outcomes and Quality of Life of Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Advanced Breast Cancer Treated With Palbociclib in the POLARIS Study.